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Mitotic gene conversions, among other recombinagenic
events, can play an important role in the multistep process
of carcinogenesis. The ability of chemicals to induce such gene
conversions can easily be monitored in the Saccharomyces
cerevisiae tester strain YHE2, a derivative of strain D7. For
the detection of drug-induced gene conversions, two mutations
in the TRP5 locus are used, trp5-12 and trp5-27. Here we
report on the characterization of the stable allele trp5-27. Our
analysis revealed two relevant mutations in trp5-27: (a) a
transition C to T at position 121 after ATG that results in
an amber stop codon and abolishes gene expression and (b)
a transversion A to T at position 1555 that creates an ochre
stop codon. Simultaneous amber and ochre suppression with
the suppressors SUP3 and SUP11, respectively, was capable
of relieving the tryptophan-requiring phenotype of strains
carrying the trpS-27 allele. These findings have implications
on the length of gene conversion tracts in conversion events
between trpS-12 and trp5-27: conversion tracts can cover
several Idlobases, if the site of the mutation hi trpS-12 lies
outside of the positions mutated hi trp5-27. Conversely, the
maximal length is limited to 1435 bp, if the mutation in
trp5-12 is located between the positions mutated hi trpS-27.
Introduction
Mitotic gene conversion is a process of nonreciprocal transfer
of genetic information between homologous chromatic! regions
of chromosomes. In cells that are heterozygous for two alleles
of a marker gene on the two homologous chromosomes, gene
conversion within the region of the marker gene can result in
the loss of heterozygosity, and a clone can develop that is
homozygous for one of the marker alleles (Wurgler, 1992). If
in proliferating tissue a cell turns homozygous for a pre-existing
mutation in a tumor suppressor gene that leads to the loss of gene
function, this loss of heterozygosity will enable the phenotypical
manifestation of the mutation and may result in increased
proliferation of the cell (Sengstag, 1994). Thereby, gene
conversions, among other recombinagenic events, represent a
possible step in the multistep process of carcinogenesis (Fearon
and Vogelstein, 1990). Chemical compounds that raise gene
conversion frequencies are, therefore, thought to contribute con-
siderably to the development of neoplasms. In addition to their
effect on cancer induction, promotion and progression, gene
conversion events leading to loss of heterozygosity can also affect
other biological functions that influence health (Wurgler, 1992).
During the last few years, the awareness of the importance of
such processes has substantially increased, and various test
systems have been designed to identify the recombinational
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properties of substances which might be indicative of their
carcinogenic potential (Sengstag, 1994). One of these test systems,
the Saccharomyces cerevisiae tester strain D7 (Zimmermann
et al., 1975), allows the detection of gene conversions
simultaneously with reversions and mitotic recombinations. As a
unicellular eukaryote, S. cerevisiae provides a readily manipulable,
yet genetically complex model organism suitable for the study
of recombinational events (Zimmermann, 1992), and since its
introduction the tester strain D7 has been extensively used for
genotoxicity testing (Zimmermann et al., 1984). As the yeast
cells lack certain enzymatic activities that can be crucial for the
activation of procarcinogens, various human enzymes have been
heterologously expressed in a yeast strain derived from D7
(Eugster et al., 1990, 1991, 1992) and are capable of conferring
such metabolic competence to yeast (Eugster et al., 1993; Eugster
and Sengstag, 1993; Sengstag et al., 1994). This approach has
proved promising in broadening the applicability of the test system.
The process of gene conversion can easily be followed in
heteroallelic diploid yeast strains that carry two defective alleles
of the same gene locus (Zimmermann, 1975). hi strain D7
(Zimmermann et al., 1975), two non-complementing alleles of
the tryptophan synthase gene TRP5 (Zalkin and Yanofsky, 1982)
are combined. Taken on their own, the two alleles trp5-12 and
trp5-27 are completely stable (trp5-27) or exert low reversion
frequencies (trp5-12, reversion frequency 10"6) that do not
interfere with gene conversion (Zimmermann and Schwaier,
1967). Conversely, the tryptophan-requiring heteroallelic diploid
D7 generates tryptophan nonrequiring convertants at a frequency
of approximately 10~5. The conversion frequency can be
increased by treatment of the cells with DNA-damaging agents
(Zimmermann et al., 1975). For our genotoxicity testing, we are
working with a ura3 derivative of D7, YHE2 (Eugster et al.,
1990). We were interested to characterize the trp5 mutations
present in our tester strain in order to gain more insight into the
gene conversion events taking place between the two trp5 alleles.
Here we report the characterization of one of the alleles, trp5-27.
Materials and methods
Yeast and bacterial strains, media and culture conditions
The construction of the S.cerevisiae strains YHE2 (a/a, ade2-40/ade2-l 19,
ilvl-92/ilvl-92, trp5-27/trp5-12, ura3b5/ura3b5), and YHE1 (a, ade2-40,
ilvl-92, trp5-27, um3A5), has previously been described (Eugster et al., 1990).
Strain YAE76 (a, ade2-119, itvl-92, trp5-lll, ura3A5) was constructed in this
laboratory. Strain JRY1631 (a, ade2-110, cyh2, his3A200, leul, fys2S01, trp5,
uru3-52) was kindly provided by Dr J.Rine. Yeast transformations were performed
as described by Klebe et al. (1983). The bacterial strain DH5aF' was used for
propagation of recombinant plasmids.
Yeast strains were grown in standard media. Minimal medium YM [0.67%
yeast nitrogen base without amino acids (Difco), 2% glucose] was appropriately
supplemented with amino acids as described by Sherman (1991). Escherichia
coli was grown in LB medium which was supplemented with 150 ^g/ml
ampicillin where appropriate.
Plasmid constructions
Piasmid pAE158 is a derivative of YEp352 (Hill et al., 1986) and contains in
its BamHl site the TRP5 gene from pYASl (Dohmen a al., 1989) as a 3.3 kb
BamHl fragment. In pAE158, TRP5 has the same orientation as lacZ. Plasmid
pAE268 is analogous to pAE158, but contains the trp5-27gent which was cloned
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from YHEl (see Results). Plasmids pAE470, pAE471, pAE475 and pAE491
are derived from pAE268 and have their BglUISall, Spell Sail, Ncol anc
BstEDJSall trp5-27 fragments, respectively, replaced by the corresponding
TRP5 sequence. Plasmids pRS313SUP3, pRS316SUP3 and pUN60SUP3 wen
constructed by introducing the 137 bp SUP3 BamHl fragment of mWJ64 (Guc
and Wu, 1982) into the BamHl sites of pRS313, pRS316 (Sikorski and Hieter,
1989) and pUN60 (Hledge and Davis, 1988), respectively. To obtain pAE492,
the blunt-ended trp5-27 BamHl fragment of pAE268 was introduced into the
XbaVNotl cleaved, blunt-ended plasmid pRS316SUP3 to give pAE342.
Subsequently, the PvuU fragment of pAE342 containing trp5-27 and SUP3 was
cloned in the PvuR cut vector pRS313. Plasmid pAE496 was constructed by doning
the SacUSall trp5-27fragment of pAE268 in the SacUSall cleaved vector pRS313.
Colony hybridization and detection
Bacterial colonies representing the &mHI//#mlIH sublibrary of YHEl in pRS316
was transferred to Pall Brodyne A transfer membranes, lysed and their DNA
bound to the filters as described by Sambrook ex al. (1989). For the detection
of 77W.5-containing colonies, the 3.3 kb BamHl fragment of pAE158 was
digoxygenin-labelled with the DIG DNA Labeling and Detection Kit from
Boehringer. Labelling, hybridization and chemiluminescent detection were
performed according to the supplier's protocols.
DNA sequence analysis
Fragments to be sequenced were subcloned in pBLKS and pBLSK (Stratagene).
DNA sequence analysis was performed on single-stranded DNA by the dideoxy
chain termination method (Sanger et al., 1977) using the Sequenase Version
2.0 DNA Sequencing Kit (US Biochemical Corporation) according to the
manufacturer's specification. [a-^SJdATP was purchased from DuPont.
Results
Cloning of the trpS-27 gene
In order to clone the trp5-27 gene, a genomic sublibrary of the
S.cerevisiae trp5-27strain YHEl was constructed in the E.coli/
S.cerevisiae shuttle vector pRS316. To this end, total DNA
isolated from YHEl was double-digested with BamHl and
HindUI, which divides the trp5-27gene in two fragments of 1815
and 1516 bp length. DNA fragments in a size range of
1.4 — 1.9 kb were purified from an agarose gel and ligated to the
BamHl and HindM cleaved vector pRS316. Four hundred and
fifty individual ampicillin resistant E. coli transformants were used
for a colony hybridization experiment (see Materials and
methods). As a probe, the 3.3 kb digoxigenin-labelled TRP5
BamHl fragment of pAE158 was taken. To confirm the identity
of the 11 clones that gave rise to positive signals, their plasmid
DNA was subjected to restriction analysis. By this procedure,
two clones representing the 1.8 and 1.5 kb fragments of the
trp5-27 were chosen for further characterization. Subsequendy,
the complete trp5-27 gene was reconstituted in the
E.coli/S.cerevisiae shuttle vector YEp352 by triple-ligating the
two individual trp5-27BamHUHindni fragments to die BamHl
cleaved YEp352 to give pAE268.
The phenotype conferred by the trp5-2 7 plasmid pAE268 was
determined by transforming strain YHEl to uracil prototrophy
with pAE268 and, as a control, with pAE158, which is a YEp352
derivative and carries the wild-type TRP5 gene. YHEl pAE268
and YHEl pAE158 were streaked on supplemented minimal
medium lacking uracil or uracil and tryptophan, and the plates
were incubated for 3 days at 30cC (Figure 1A). In contrast to
YHEl transformed with the 7RPJ-carrying plasmid, YHEl
containing the trp5-2 7 plasmid was unable to grow on medium
lacking tryptophan. Thus, plasmid pAE268 does not confer
tryptophan prototrophy to YHEl and, therefore, presumably
contains a mutation in its trp5-27 allele that distinguishes
it from pAE158.
Mapping and sequencing of an amber mutation in trp5-27
Since knowledge of the underlying mutation(s) in the trp5-2 7 and
trp5-12 alleles present in the 5. cerevisiae strains D7 and YHE2











Fig. 1. (A) Comparison of the tryptophan phenotypes conferred to YHEl by
plasmids carrying TRP5 (pAE158) and trp5-27 (pAE268). YHEl pAE158
and YHEl pAE268 were streaked on supplemented minimal medium lacking
uracil (—ura) or uracil and tryptophan (-ura -trp) and incubated for 3
days at 30°C. (B) Amber suppression in YHEl (trp5-27) and YAE76
(trp5-lll). The strains transformed with a vector control (pRS316) or an
amber suppressor containing plasmid (pRS316SUP3) were pregrown in
supplemented minimal medium to stationary phase and diluted to an
absorbance at 600 nm of 0.3. 5 /il of these cell suspensions and of 1:10,
1:100 and 1:1000 dilutions were placed on supplemented minimal medium
lacking uracil (—ura) or uracil and tryptophan (-ura -trp). Plates were
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Fig. 2. Replacement of plasmid-borne trp5-27 segments by wild-type TRP5
and determination of the phenotype conferred by these plasmids. The white
and grey boxes represent the TRP5 and trp5-27 sequences, respectively. The
phenotypes conferred by the plasmids were determined in strain YHEl and
are indicated as (+) for tryptophan prototrophy and ( - ) for tryptophan
auxotrophy. By testing the tryptophan phenotype of JRY1631 cotransformed
with respective trpS plasmids and pRS313SUP3, novel trp5 alleles derived
from trp5-27 were identified whose tryptophan conferring phenotype was
(+) or was not (—) amber suppressible (n.a., not applicable). The direction
and approximate length of the TRPS open reading frame are indicated by
the arrow. Selected restriction shes are indicated (Ba = BamHl,
Bg = BglU, Bs = flirEn, N = Ncol, Sp = SpeV).
events, we were interested in localizing the site of the mutation(s)
in the trp5-27 allele. Therefore, we replaced fragments of
increasing length of the trp5-27 plasmid pAE268 by the
corresponding TRP5 fragment and tested the tryptophan phenotype
conferred by the new constructs (Figure 2). For this purpose,
YHEl was transformed with each novel construct and Ura+
transformants were streaked on supplemented minimal medium
lacking uracil or tryptophan and uracil. A tryptophan non-
requiring phenotype was only observed when trp5-2 7 sequences
downstream of the BstER she were replaced by the corresponding
wild-type sequences, while replacement of the sequences down-
stream of the Spel site was not sufficient to confer tryptophan
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Fig. 3. Amber suppression of various trpS alleles in JRY1631. JRY1631
cotransformed with the indicated plasmids was grown to stationary phase in
liquid medium and diluted to 3 x 106 cells/ml; 5 fd of these and of 1:10,
1:100 and 1:1000 dilutions were spotted on supplemented minimal medium
lacking uracil and histidine (—ura —his) or uracil, histidine and tryptophan
(-ura -his -trp). The plates were incubated for 2 days at 30°C.
prototrophy. This allowed us to map the site(s) of the mutation(s)
in trp5-27 to a 380 bp BstEWSpel fragment. To elucidate the
exact nature of the mutation(s) assumed to lie in this DNA
segment, the DNA sequence of the corresponding trp5-27
fragment was determined. The fragment was cloned into pBLKS
and pBLSK, single-stranded DNA was prepared and sequenced
according to the dideoxy method. Comparison of the trp5-27
sequence with the wild-type TRPS sequence revealed a transition
C to T at nucleotkle position 121 after ATG. This mutation results
in an amber stop codon TAG in trp5-27and represents a potential
cause for the Trp~ phenotype observed for the trp5-27 allele.
Attempted suppression of the trp5-27 amber mutation
To determine whether the amber mutation found on trp5-27
plasmid pAE268 was the only mutation responsible for the
tryptophan auxotrophic phenotype conferred by the plasmid, we
attempted to suppress this Trp" phenotype with the amber
suppressor SUP3. In order to achieve this objective, S.cerevisiae
strain JRY1631 with the relevant genotype trp5, his3A200,
ura3-52 was cotransformed with either YEp352 or pAE268 as
URA3 plasmids and either pRS313 or pRS313SUP3 as HIS3
plasmids. Ura+/His+ transformants were grown in liquid
culture to stationary phase. Aliquots of serial dilutions were
spotted on supplemented minimal medium lacking uracil and
histidine or tryptophan, uracil and histidine, and the plates were
incubated at 30°C for 2 days (Figure 3). The trp5 mutation of
JRY1631 was not suppressible with SUP3 as shown by the
inability of JRY1631 pRS316 pRS313SUP3 to grow without
tryptophan. Surprisingly, JRY1631 carrying pAE268 and the
SWJ-containing plasmid was also unable to grow without
tryptophan, indicating that die Trp" phenotype conferred by
pAE68 was not amber-suppressible.
To make sure that the inability to amber-suppress JRY1631
pAE268 was not due to a cloning artefact on pAE268, but that
the cloned trp5-27 allele was identical with the allele present in
YHE1, we attempted to suppress the tryptophan auxotrophic
phenotype of YHE1 with the amber suppressor SUP3. YHEI was
transformed with the control vector pRS316 and with pRS316SUP3.
In parallel, strain YAE76, which has an amber-suppressible
tryptophan-requiring phenotype (A.Ehrenhofer-Murray and
C.Sengstag, unpublished), was transformed with die same
plasmids in order to confirm functional expression of SUP3 in
pRS316SUP3. Ura+ transformants were grown in liquid culture
to stationary phase and diluted to 3 x 10° cells/ml. Aliquots of
serial dilutions were spotted on supplemented minimal medium
lacking uracil or tryptophan and uracil, and the plates were
incubated at 30°C for 3 days (Figure IB). Only the amber
suppression control strain YAE76 containing the SUP3 plasmid
could grow without tryptophan, while trp5-27 strain YHEI
containing SUP3 was unable to grow. Therefore, as found for
the trp5-27 allele on pAE268, the trp5-27 mutation of YHEI is
not suppressible with the amber suppressor SUP3. These results
suggested either that SUP3 was not the appropriate amber
suppressor for trp5-27, or that there was a second mutation
present in trp5-27 that restricted its amber suppressibility.
Amber suppression of novel trpS alleles and identification of a
second mutation in trp5-27
To rule out the possibility that the inability of SUP3 to suppress
the Trp~ phenotype of trp5-27 was due to die nature of this
suppressor, we attempted to amber-suppress novel trp5 alleles
derived from trp5-27. This was achieved by exchanging
fragments of pAE268 for the corresponding wild-type TRPS
fragment, cotransforming JRY1631 with die new constructs and
either pRS313 or pRS313SUP3 to uracil and histidine prototrophy
and determining die tryptophan phenotype of die transformants
by streaking diem on medium lacking uracil and histidine or
tryptophan, uracil and histidine (Figure 2; c.f. also Figure 3).
A trpS allele present on pAE470 widi the sequence downstream
of the BglU site replaced by wild-type sequences was suppressible
widi SUP3, while substitution of the trpS-27 sequences
downstream of the Ncol site conferred no suppressible phenotype.
These results demonstrated diat me suppressor SUP3 was in fact
capable of suppressing certain trpS alleles derived from trpS-27.
In addition, these results strongly suggested die presence of a
further mutation widiin a 606 bp BglWNcol fragment oitrpS-27
diat interferes widi amber suppression. In order to identify tiiis
potential second mutation, die trpS-27 BglWNcol fragment was
subjected to DNA sequence analysis. This revealed a transversion
A to T at nucleotide position 1555 after ATG. This mutation
creates an ochre stop codon TAA in trpS-27 diat presumably was
responsible for the inability to amber-suppress trpS-27.
Simultaneous amber and ochre suppression of trp5-27
To confirm diat die amber and ochre mutations of trpS-27 at
positions 121 and 1555 after ATG were the only mutations
responsible for its tryptophan-requiring phenotype, we undertook
experiments to suppress bodi mutations simultaneously. To diis
end, die HIS3 plasmids pAE496 and pAE492 were constructed
diat contain tire trp5-27gznt from YHEI alone or with the amber
suppressor SUP3, respectively. JRY1631 was cotransformed with
pAE496 or pAE492 as HIS3 plasmids and pRS316 or pUN60
as URA3 plasmids. Plasmid pUN60 carries die ochre suppressor
SUP11 (Elledge and Davis, 1988). Histidine and uracil proto-
trophic transformants were subsequendy streaked on supplemented
minimal medium lacking histidine and uracil or tryptophan,
histidine and uracil, and die plates were incubated for 3 days
at 30°C (Figure 4). The Trp" phenotype of JRY1631 was not
suppressed with SUP3 or SUP11 alone or in combination (data
not shown). Similarly, a JRY1631 transformant containing die
trpS-2 7 plasmid and eidier SUP3 or SUP 11 was unable to grow
widiout tryptophan, whereas a transformant expressing trpS-27
and both SUP3 and SUP 11 showed a tryptophan prototrophic
phenotype. This result clearly demonstrated that simultaneous
amber and ochre suppression was necessary and sufficient to cure
die Trp" phenotype of trp5-27. Similarly, die Trp" phenotype
of YHEI was suppressed by a plasmid containing both suppressors
SUP3 and SUP 11 (data not shown).
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Fig. 4. Simultaneous amber and ochre suppression of trp5-27. JRY1631
transformants were streaked on supplemented minimal medium lacking
uracil and histidine (—ura —his) or uracil, histidine and tryptophan (—ura
-his -trp). The plates were incubated at 30°C for 3 days.
Discussion
The trp5-27 allele, one of the two defective alleles of the TRP5
locus (Zalkin and Yanofsky, 1982) in the diploid S.cerevisiae
genotoxicity strain D7 (Zimmermann et al., 1975), has found
extensive use in the detection and quantification of drug-induced
gene conversion events. Despite its broad application, the
mutation in trp5-27 so far has not been characterized and, thus,
little is known about the nature of gene conversion events in D7
that produce tryptophan prototrophic convertants.
In this study, we have identified two relevant mutations in
trpS-2 7 that are responsible for its stable tryptophan auxotrophic
phenotype. At nucleotide position 121 after ATG, trp5-27
contained a transition C to T that results in an amber stop codon.
This stop codon presumably terminates translation, giving rise
to a truncated and probably abortive Trp5 gene product. The fact
that suppression of this mutation with the amber suppressor SUP3
(Guo and Wu, 1982) did not suffice to cure the Trp~ phenotype
was not due to inherent characteristics of SUP3, since other, novel
trp5 alleles derived from trp5-27 were in fact suppressible with
SUP3. It rather indicated the presence of a second mutation in
the trp5-27 gene. It was subsequently detected as a transversion
A to T at nucleotide position 1555 after ATG and creates an ochre
stop codon. Ochre suppression alone with SUP 11 (Elledge and
Davis, 1988) in trp5-27did not result in tryptophan prototrophy.
Conversely, simultaneous amber and ochre suppression was
capable of relieving the tryptophan requirement of strains carry-
ing trpS-27. Therefore, the two stop codons were the mutations
relevant for the Trp~ phenotype of trp5-27.
This finding has implications concerning the length of gene
conversion tracts in conversion events between trp5-27 and
trp5-12 that are successful in forming Trp+ convertants in D7.
In S.cerevisiae, gene conversion tracts are usually continuous,
information being transferred as a single block from one
chromosome to another (Borts and Haber, 1989). If transfer is
to be directed from trp5-12 to np5-27 (Figure 5A), a contiguous
DNA stretch has to cover both mutations of trp5-27 and thus
requires a minimal length of 1435 bp. Consequently, the assumed
mutation in trp5-12 would lie outside of the positions mutated
in trp5-27, and therefore would be located either upstream of
position 121 or downstream of position 1555, presumably within
the TRP5 open reading frame that ends at position 2619. In such







Fig. 5. Schematic representation of possible gene conversion events between
trp5-27 and trp5-12 that result in Trp+ convertants in D7. The approximate
site of the relevant mutations in trp5-27 and one possible location of a
mutation in trp5-12 are designated by crosses (X). The directions of
information transfer during gene conversion are indicated by arrows.
Conversion tracts can cover several kilobases, if the she of the mutation in
trp5-12 lies outside of the positions mutated in trp5-27 (A and B).
Conversely, the maximal tract length is limited to 1435 bp, if the mutation
in trp5-12 is located between die positions mutated in trp5-27 (C).
downstream or upstream of the trp5-12 mutation, respectively.
Likewise, if information transfer proceeds from trp5-27 to a
trp5-12 allele whose mutant site lies outside of the positions
mutated in trpS-27, the conversion tract could also span several
kilobases (Figure 5B). Conversely, its size would be limited to
a maximum of 1435 bp, if the mutation in trp5-12 was located
between the positions mutated in trp5-27 (Figure 5Q. Judd and
Petes (1988) measured the tract length of mitotic conversions of
the ura3-3 allele at the URA3 locus and reported a minimum
average conversion tract lengtii of 0.9 ± 0.8 kb. In 40% of the
cases, though, the average tract length was between 4 and 10 kb.
We therefore favour the model of the mutated site in trp5-12 ly-
ing upstream of position 121 or downstream of position 1555
after ATG (Figure 5A and B), also since the conversion frequency
of D7 (10~5; Zimmermann et al., 1975) compares well to the
frequency in the ura3-3/URA3 strain (4 X 10~6; Judd and
Petes, 1988).
In light of these results, the characterization of the trp5-12 allele
of D7 represents an important task and will give more precise
information on the direction and extent of information transfer
during gene conversion between the two alleles.
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